Skip to main content

Table 2 Prevalence of metabolic syndrome

From: Prevalence and factors associated with nonalcoholic fatty liver disease in shanghai work-units

   Male    Female    Total  
  NAFLD (n(%)) Non NAFLD (n(%)) P NAFLD (n(%)) Non NAFLD (n(%)) P NAFLD (n(%)) Non NAFLD (n(%)) P
obesity 1279(29.53) 419(9.68) .000 326(11.55) 167(5.92) .000 1605(22.44) 586(8.19) .000
Abdominal obesity 966(22.31) 338(7.81) .000 316(11.20) 206(7.30) .000 1282(17.93) 544(7.61) .000
BP>130/85 or HBP 1012(23.37) 498(11.50) .000 321(11.37) 302(10.70) .000 1333(18.64) 800(11.18) .000
dyslipidemia 1137(26.26) 396(9.15) .000 283(10.03) 229(8.11) .000 1420(19.85) 625(8.74) .000
FPG>5.6 or 2-DM 420(9.70) 182(4.20) .000 130(4.61) 83(2.94) .000 550(7.69) 265(371) .000
  1. Metobolic syndrome: (1) Obesty: Body mass index ≥25kg/m2; abdominal obesity: ≥90cm(male), ≥80cm(female); (2) Blood pressure (BP)≥130/85mmHg Or hypertension (HBP); (3) Dyslipidemia: Triglycerides (TG)≥1.7mmol/L, and/or High Density Lipoprotein cholesterol (HDL)≤1.03mmol/L, (male) <1.29mmol/L (female); (4) Fasting blood glucose (FPG)≥5.6 mmol/L Or type 2 diabetes (2-DM).